Human Growth Hormone
Human growth hormone is a 191-amino-acid protein hormone. Somatropin products are prescription biologics rather than short research peptides.
The short version
- Why people discuss it
- Discussed for muscle and body composition, recovery and anti-aging; treatment of confirmed growth-hormone deficiency is a separate medical context. Community interest does not establish benefit or a suitable treatment.
- What it is
- Human growth hormone is a 191-amino-acid protein hormone. Somatropin products are prescription biologics rather than short research peptides.
- Biggest caution
- Labeled somatropin evidence applies to specific diagnoses, products and monitored patients. It does not establish anti-aging, bodybuilding or generalized recovery use, or validate an unverified product.
- Stack context
- Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.
Dose and frequency reference
Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.
Sources report different amounts or schedules; the reference below is a named example, not a consensus.
Subcutaneous injection
Community reference · Not clinical guidance- Amount
- 1–2 IU
- Frequency
- Once daily, 5–7 days weekly
- Duration / phase
- Reported example: 6 months on, 2 months off
Legacy wellness convention, not a somatropin replacement prescription. Medical replacement is indication- and response-specific; the new source escalates beyond this amount. Reference only; this does not establish safety, effectiveness or individual suitability.
Reference source · reviewed 2026-09-12Compare reported schedules
Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.
- PeptideDosages — saved source reviewed September 27, 2026
0.2→0.9 mg SC daily by week 8, optional 1.7 mg by week 16; 8–12-week cycles.
Evidence & sources · Community source profile
AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.
- AxonRep community research synthesisAxonRep synthesis · Checked 2026-09-12
- DailyMed: Genotropin somatropin prescribing informationProduct label · Checked 2026-09-12
- PeptideDosages — saved source reviewed September 27, 2026Community reference · Checked 2026-09-27